Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
Clinical trial NCT06864403 · RECRUITING
Trial details
- NCT number
- NCT06864403
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-12
- Primary completion
- 2027-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.